Clough Capital Partners L P Takes Position in Select Medical Holdings Corporation $SEM

Clough Capital Partners L P acquired a new position in Select Medical Holdings Corporation (NYSE:SEM) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 173,010 shares of the health services provider’s stock, valued at approximately $2,569,000.

A number of other hedge funds also recently added to or reduced their stakes in SEM. 8 Knots Management LLC purchased a new position in Select Medical in the 2nd quarter worth approximately $26,568,000. Millennium Management LLC grew its position in Select Medical by 407.9% in the 3rd quarter. Millennium Management LLC now owns 1,590,339 shares of the health services provider’s stock worth $20,420,000 after purchasing an additional 1,277,233 shares during the period. Adage Capital Partners GP L.L.C. bought a new stake in Select Medical in the 4th quarter worth approximately $17,603,000. Western Standard LLC bought a new stake in shares of Select Medical during the 3rd quarter valued at $13,551,000. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Select Medical by 4.3% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,606,269 shares of the health services provider’s stock valued at $246,604,000 after acquiring an additional 684,695 shares during the period. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts recently weighed in on SEM shares. Wall Street Zen downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, March 9th. Weiss Ratings upgraded shares of Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, June 4th. Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 target price (down from $19.00) on shares of Select Medical in a research report on Tuesday, March 3rd. Zacks Research upgraded shares of Select Medical from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. Finally, Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. One investment analyst has rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, Select Medical has a consensus rating of “Hold” and a consensus target price of $15.50.

Select Medical Price Performance

NYSE SEM opened at $16.54 on Thursday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.15 and a current ratio of 1.15. The firm’s 50 day moving average price is $16.48 and its 200-day moving average price is $15.86. Select Medical Holdings Corporation has a 52-week low of $11.65 and a 52-week high of $16.99. The company has a market cap of $2.05 billion, a PE ratio of 15.60, a P/E/G ratio of 0.96 and a beta of 1.01.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same period in the previous year, the company earned $0.44 EPS. The company’s revenue was up 5.0% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Sell-side analysts forecast that Select Medical Holdings Corporation will post 1.26 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 28th. Investors of record on Thursday, May 14th were given a dividend of $0.0625 per share. The ex-dividend date of this dividend was Thursday, May 14th. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. Select Medical’s dividend payout ratio is presently 23.58%.

Select Medical declared that its board has initiated a share buyback program on Thursday, February 19th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the health services provider to buy up to 49.5% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.